Posts

Showing posts with the label Idiopathic Thrombocytopenic Purpura (ITP) competitive landscape

Idiopathic Thrombocytopenic Purpura (ITP) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
 Idiopathic Thrombocytopenic Purpura (ITP) is a condition characterized by a low platelet count in the blood, with no known cause. This condition is also called Immune Thrombocytopenic Purpura, which is believed to be related to antibodies against platelets. The normal platelet count in adults is between 150,000 to 450,000/mm3. A low platelet count below 50,000/mm3 increases the risk of bleeding from trauma, while counts below 20,000/mm3 increase the risk of spontaneous bleeding. ITP can be acute or chronic. Acute ITP is the most common form of the disorder and is commonly seen in young children, typically between the ages of 2 to 6 years. It usually follows a viral illness, and symptoms disappear within a few weeks. Chronic ITP, on the other hand, can occur at any age, and symptoms can last for several years. Females are more likely to contract this form of the disease, and it can often recur. The acute form of ITP may be caused by drug exposure or infection. In contrast, the chro...